InMode Expects Strong Q3 Results with Gross Margins up to 79%—FY 2025 Guidance Reaffirmed


Re-Tweet
Share on LinkedIn

InMode Expects Strong Q3 Results with Gross Margins up to 79%—FY 2025 Guidance Reaffirmed

Robust Preliminary Q3 Results Signal Confidence in Outlook

InMode Ltd. (Nasdaq: INMD) has announced preliminary results for its third quarter 2025 financials, setting an optimistic tone for the remainder of the year. Management projects Q3 revenue between $92.5 million and $93 million, paired with a healthy non-GAAP gross margin in the 77% to 79% range. Notably, the company has reiterated its full-year 2025 revenue guidance, expecting $365 million to $375 million—a sign of steady momentum and disciplined execution despite broader market uncertainties.

Financial Snapshot: Q3 Revenue and Margins at a Glance

Metric Q3 2025 (Preliminary) FY 2025 Guidance
Revenue $92.5M–$93.0M $365M–$375M
Non-GAAP Gross Margin 77%–79% N/A

For context, non-GAAP gross margin excludes share-based compensation and is often used to compare operational efficiency without one-off accounting impacts. With these preliminary figures, InMode continues to distinguish itself in the competitive medical technology space, emphasizing a business model that is both high-growth and highly profitable.

Management’s Reiteration of Full-Year Guidance Highlights Stability

Despite ongoing market challenges, InMode’s reaffirmation of its annual revenue outlook reflects management’s confidence in the company’s growth trajectory. The projected Q3 numbers keep InMode well on track to hit its full-year guidance, underlining a consistent sales pipeline and solid demand across its portfolio of radio frequency (RF) devices.

Investors should note that these estimates remain subject to final adjustments when official Q3 results are released before the market opens on November 5, 2025.

Key Investor Events: Upcoming Earnings Call Set for November 5

Stakeholders eager for further details can mark their calendars for InMode’s Q3 2025 earnings conference call, scheduled for November 5, 2025, at 8:30 a.m. Eastern Time. The event will feature Chief Executive Officer Moshe Mizrahy, Chief Financial Officer Yair Malca, and Chief Technology Officer Dr. Michael Kreindel, offering deeper insights into financials and operational performance.

The call will be webcast live and a replay will be available on the InMode investor website. Investors are encouraged to pre-register for the conference or join using local or international dial-in numbers as listed in the press release.

What Should Investors Watch for Next?

With InMode projecting high gross margins and maintaining annual revenue guidance, the company’s focus on innovative RF medical technology continues to bear fruit. The consistency in performance, despite evolving global dynamics, signals underlying resilience in both strategy and market demand.

As InMode prepares to release full Q3 results, investors may want to keep an eye on margins, segment performance, and commentary around growth drivers on the November 5th call. Given management’s stable outlook and historical execution, these numbers could further validate the strength of InMode’s business model in the coming quarters.


Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.


About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.


NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.


The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.


Disclosure: This article was generated with the assistance of AI

Market Data Delayed 15 Minutes